Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Sphinx, the new function claim was only submitted on the 29th of August (one month ago) once SAMR finally officially released the "Implementation Rules for New Functions and Product Technology Evaluation of Health Foods" on 28th August.
The Technical Specifications for Testing and Evaluation of Health Food (2003 Version) was abolished in July 2018 so we can hardly blame PXS or By-Health for the delay. The good thing was By-Health were ready and waiting.
We know what we're waiting for.
The link with ByHealth, with their chief scientist having started his training with Provexis is the significant part of the story. All of the years developing Fruitflow, all of the added health function, but still they revert to the original one for Blue Cap approval. They have massive promotional capabilities, and have been preparing their PR offerings for ages. This is where the big numbers (and sp) is achievable, the extra revenues could unlock to door to proper promotion in other markets.
In that respect, we still have to wait. For the new trading pattern, we can hope to start gaining some insights.
I’m not expecting anything that will move the sp , more cut & paste and hopeful link ups with mysterious 3rd parties I expect . The “ New” function claim will be talked about even though it’s 15 months old now . Nothing happens with any pace at pxs I’m afraid . I hold in hope though!
Like many AIM CEO's Ian Ford has earned many millions by "running" a loss-making outfit. It really is a gravy train isn't it? 2009 to 2023 and yet to make a profit! It never really lived up to the potential and probably never will. Good product though.
Although there is no requirement to publish them I hope we get some (unofficial) figures for March to September.
Will we break even?
- no trade in jan, possibly part of Feb too
- loss due to lockdowns
- majority of customers transferred, not all.
We should see a some revenue increase, but not sure we’ll break even for year 22/23. Only 1 day until we find out.
Will it be 14 years in row 'No profit? OR being positive:Loss decreasing x
They don't want to sell any.
What test results are we waiting on?
The results will be I reckon disappointing which is why they got the positive news out 1st to lift the SP , this hasn't worked however people buying under 0.6p now. I think it will be going lower. Test results a long way off. GLA
By Health haven't got Blue Cap approval yet, so the orders that could be multiples of any prior order are still pending as far as we can tell.
Therefore, mu expectations are modest. Will the cash requirement be conclusively addressed? Doubt it, I think it will still be the sword of Damocles' over the sp.
Not that I know, only management do.
I'm just teasing, I don't think anyone expects anything other than the usual "multiples of existing sales" guff. I'm actually tempted to buy another 500k at the current price though. Any whiff of good news could easily send this over a penny IMHO.
The first sales were not until some time in Feb?. So we will only get some Feb and all March on the new structure. Then I am not confident that they will split that out in the results and if they do it will be a bit meaningless. Hopefully we get some good news, but I think December is where we can start to make sense of their forecasts. I think the Friday RNS will be more of the same, but hope I am wrong.
Come on Dr_H, stop kicking the can down the road. c. £6m profit from the remaining stock you said, surely that'll be £1.5 million in the first quarter then? No? No, thought not, more of the same, as you now (like me) suspect. You never know though...
I suspect it will be more of the same. December is where we get a better understanding, as it will be a full 6 months on the new structure. That means that terms like 'multiple' and 'significant multiples' start to gain some meaning.
A bit of positivity in the results would go down a treat :)
Find out soon.
Could they be any more positive?
This is another massive big up for Fruitflow, we can only hope that they can persuade the huge Chinese middle class population that cardiovascular health is worth investing in. By the looks of the market growth over there, they are getting the message. Launching in to such a fast growing sector is vital, just hope the state boffins will agree.
"The number of cardiovascular patients in my country has reached 330 million. These people should pay attention!"
"As the first company to apply for new functions, behind the approval document are countless sweats and sleepless nights by the By-Health R&D team."
https://www-163-com.translate.goog/dy/article/IFAPNQ6G05534E2F.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
"The cardiovascular and cerebrovascular health market has an even higher year-on-year growth rate, hitting a high growth rate of 91% in Q1 of 2023."
"The growth rate of cross-border channels in the cardiovascular and cerebrovascular health market is even stronger, hitting a high growth rate of 97% in Q1 of 2023."
"Tomatoes received widespread attention as a nutrient-rich food at the recent Health and Nutrition Congress academic session."
"Water-soluble tomato concentrate, a tomato essence obtained through special processing, was also mentioned at the meeting. It is more easily absorbed by the body than regular tomatoes and has no risk of bleeding. "
https://zhuanlan-zhihu-com.translate.goog/p/657827019?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Would be nice to get the results on Monday morning but my guess is Friday.
To me the"GUT HEART AXIS" has a ring to it and could be useful marketing tagline
News next week or will he leave it to last moment as usual
W$
As the date on the video says "Sep 21, 2023" I assume that its new.
Note that it also mentions the Gut-Heart Axis.
http://postimg.cc/23d96pCY
Hi gixer,
Is that new video or old video?
I got offered 3 mill today at 64.
MM had picked them up on the RSP.
I bought 1m at 63.5
They are heavy at the moment for some reason.
Don't forget By-Health is also a distributor for Fruitflow and might have already been selling it to other businesses.